Elevated Cyclic AMP Inhibits Mycobacterium tuberculosis-Stimulated T-cell IFN-γ Secretion Through Type I Protein...

Area of Science:

• Immunology
• Molecular Biology
• Infectious Diseases

Background:

• Cyclic adenosine monophosphate (cAMP) plays a key role in immune regulation, but its specific function in tuberculosis (TB) infection is not well understood.
• Interferon-gamma (IFN-γ) is a critical cytokine for controlling Mycobacterium tuberculosis (Mtb) infection.

Purpose of the Study:

• To investigate the levels of cAMP in peripheral blood mononuclear cells (PBMC) of tuberculosis patients.
• To elucidate the mechanisms by which cAMP suppresses IFN-γ production in the context of TB infection.

Main Methods:

• Measurement of cAMP levels in PBMC from tuberculosis patients and latent tuberculosis infected (LTBI) subjects.
• Analysis of transcription factors (CREB, ATF-2, c-Jun) and microRNA (miR155) expression.
• Inhibition of IFN-γ production using PKA type I specific cAMP analogs.
• Assessment of the effects of IL-10, TGF-β1 neutralization, and IL-12 supplementation on IFN-γ production.

Main Results:

• Tuberculosis patients exhibited significantly higher cAMP levels in PBMC compared to LTBI subjects, inversely correlating with IFN-γ production.
• Expression of CREB, ATF-2, and c-Jun was reduced in tuberculosis patients.
• PKA type I specific cAMP analogs suppressed Mtb-stimulated IFN-γ production by inhibiting the promoter binding activities of CREB, ATF-2, c-Jun, and miR155.
• Neutralizing IL-10 and TGF-β1 or adding IL-12 restored IFN-γ production suppressed by cAMP.

Conclusions:

• Increased cAMP levels inhibit IFN-γ production in tuberculosis infection through the PKA type I pathway.
• The findings highlight a novel mechanism of immune evasion by Mtb involving cAMP-mediated suppression of key immune signaling pathways.